ENTITY
CureVac NV

CureVac NV (CVAC US)

11
Analysis
Health CareUnited States
CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.
more
Company Presentation10 Sep 2024 19:00
Company Presentation24 Apr 2024 21:00
Company Presentation14 Nov 2023 22:00
Company Presentation25 Apr 2023 21:00
Company Presentation06 Jan 2023 22:00
x